Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa
| dc.contributor.author | Nglazi, Mweete | en_ZA |
| dc.contributor.author | Kranzer, Katharina | en_ZA |
| dc.contributor.author | Holele, Pearl | en_ZA |
| dc.contributor.author | Kaplan, Richard | en_ZA |
| dc.contributor.author | Mark, Daniella | en_ZA |
| dc.contributor.author | Jaspan, Heather | en_ZA |
| dc.contributor.author | Lawn, Stephen | en_ZA |
| dc.contributor.author | Wood, Robin | en_ZA |
| dc.contributor.author | Bekker, Linda-Gail | en_ZA |
| dc.date.accessioned | 2015-11-18T03:54:16Z | |
| dc.date.available | 2015-11-18T03:54:16Z | |
| dc.date.issued | 2012 | en_ZA |
| dc.description.abstract | BACKGROUND: Very few data are available on treatment outcomes of adolescents living with HIV infection (whether perinatally acquired or sexually acquired) in sub-Saharan Africa. The present study therefore compared the treatment outcomes in adolescents with those of young adults at a public sector community-based ART programme in Cape Town, South Africa. METHODS: Treatment outcomes of adolescents (9-19 years) were compared with those of young adults (20-28 years), enrolled in a prospective cohort between September 2002 and June 2009. Kaplan-Meier estimates and Cox proportional hazard models were used to assess outcomes and determine associations with age, while adjusting for potential confounders. The treatment outcomes were mortality, loss to follow-up (LTFU), immunological response, virological suppression and virological failure. RESULTS: 883 patients, including 65 adolescents (47 perinatally infected and 17 sexually infected) and 818 young adults, received ART. There was no difference in median baseline CD4 cell count between adolescents and young adults (133.5 vs 116 cells/muL; p = 0.31). Overall mortality rates in adolescents and young adults were 1.2 (0.3-4.8) and 3.1 (2.4-3.9) deaths per 100 person-years, respectively. Adolescents had lower rates of virological suppression (< 400 copies/mL) at 48 weeks (27.3% vs 63.1%; p < 0.001). Despite this, however, the median change in CD4 count from baseline at 48 weeks of ART was significantly greater for adolescents than young adults (373 vs 187 cells/muL; p = 0.0001). Treatment failure rates were 8.2 (4.6-14.4) and 5.0 (4.1-6.1) per 100 person-years in the two groups. In multivariate analyses, there was no significant difference in LTFU and mortality between age groups but increased risk in virological failure [AHR 2.06 (95% CI 1.11-3.81; p = 0.002)] in adolescents. CONCLUSIONS: Despite lower virological suppression rates and higher rates of virological failure, immunological responses were nevertheless greater in adolescents than young adults whereas rates of mortality and LTFU were similar. Further studies to determine the reasons for poorer virological outcomes are needed. | en_ZA |
| dc.identifier.apacitation | Nglazi, M., Kranzer, K., Holele, P., Kaplan, R., Mark, D., Jaspan, H., ... Bekker, L. (2012). Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. <i>BMC Infectious Diseases</i>, http://hdl.handle.net/11427/15059 | en_ZA |
| dc.identifier.chicagocitation | Nglazi, Mweete, Katharina Kranzer, Pearl Holele, Richard Kaplan, Daniella Mark, Heather Jaspan, Stephen Lawn, Robin Wood, and Linda-Gail Bekker "Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa." <i>BMC Infectious Diseases</i> (2012) http://hdl.handle.net/11427/15059 | en_ZA |
| dc.identifier.citation | Nglazi, M. D., Kranzer, K., Holele, P., Kaplan, R., Mark, D., Jaspan, H., ... & Bekker, L. G. (2012). Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC infectious diseases, 12(1), 21. | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Nglazi, Mweete AU - Kranzer, Katharina AU - Holele, Pearl AU - Kaplan, Richard AU - Mark, Daniella AU - Jaspan, Heather AU - Lawn, Stephen AU - Wood, Robin AU - Bekker, Linda-Gail AB - BACKGROUND: Very few data are available on treatment outcomes of adolescents living with HIV infection (whether perinatally acquired or sexually acquired) in sub-Saharan Africa. The present study therefore compared the treatment outcomes in adolescents with those of young adults at a public sector community-based ART programme in Cape Town, South Africa. METHODS: Treatment outcomes of adolescents (9-19 years) were compared with those of young adults (20-28 years), enrolled in a prospective cohort between September 2002 and June 2009. Kaplan-Meier estimates and Cox proportional hazard models were used to assess outcomes and determine associations with age, while adjusting for potential confounders. The treatment outcomes were mortality, loss to follow-up (LTFU), immunological response, virological suppression and virological failure. RESULTS: 883 patients, including 65 adolescents (47 perinatally infected and 17 sexually infected) and 818 young adults, received ART. There was no difference in median baseline CD4 cell count between adolescents and young adults (133.5 vs 116 cells/muL; p = 0.31). Overall mortality rates in adolescents and young adults were 1.2 (0.3-4.8) and 3.1 (2.4-3.9) deaths per 100 person-years, respectively. Adolescents had lower rates of virological suppression (< 400 copies/mL) at 48 weeks (27.3% vs 63.1%; p < 0.001). Despite this, however, the median change in CD4 count from baseline at 48 weeks of ART was significantly greater for adolescents than young adults (373 vs 187 cells/muL; p = 0.0001). Treatment failure rates were 8.2 (4.6-14.4) and 5.0 (4.1-6.1) per 100 person-years in the two groups. In multivariate analyses, there was no significant difference in LTFU and mortality between age groups but increased risk in virological failure [AHR 2.06 (95% CI 1.11-3.81; p = 0.002)] in adolescents. CONCLUSIONS: Despite lower virological suppression rates and higher rates of virological failure, immunological responses were nevertheless greater in adolescents than young adults whereas rates of mortality and LTFU were similar. Further studies to determine the reasons for poorer virological outcomes are needed. DA - 2012 DB - OpenUCT DO - 10.1186/1471-2334-12-21 DP - University of Cape Town J1 - BMC Infectious Diseases LK - https://open.uct.ac.za PB - University of Cape Town PY - 2012 T1 - Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa TI - Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa UR - http://hdl.handle.net/11427/15059 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15059 | |
| dc.identifier.uri | http://dx.doi.org/10.1186/1471-2334-12-21 | |
| dc.identifier.vancouvercitation | Nglazi M, Kranzer K, Holele P, Kaplan R, Mark D, Jaspan H, et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infectious Diseases. 2012; http://hdl.handle.net/11427/15059. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | BioMed Central Ltd | en_ZA |
| dc.publisher.department | Desmond Tutu HIV Centre | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License | en_ZA |
| dc.rights.holder | 2012 Nglazi et al; licensee BioMed Central Ltd. | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/2.0 | en_ZA |
| dc.source | BMC Infectious Diseases | en_ZA |
| dc.source.uri | http://www.biomedcentral.com/bmcinfectdis/ | en_ZA |
| dc.subject.other | antiretroviral | en_ZA |
| dc.subject.other | adolescents | en_ZA |
| dc.subject.other | outcomes | en_ZA |
| dc.subject.other | mortality | en_ZA |
| dc.subject.other | virological failure | en_ZA |
| dc.subject.other | Africa | en_ZA |
| dc.title | Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Nglazi_Treatment_outcomes_2012.pdf
- Size:
- 211.11 KB
- Format:
- Adobe Portable Document Format
- Description: